speb/financial-data huggingface dataset:
CVX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -3011000000.00
CVX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 983000000.00
CVX cash_flow (quarterly, 2025-06-30) — Change In Receivables: 1982000000.00
CVX cash_flow (quarterly, 2025-06-30) — Change In Tax Payable: -356000000.00
CVX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 253000000.00
CVX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 1952000000.00
CVX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -841000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Common Stock: 1832000000.00
CVX cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -2934000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 146417000000.00
CVX cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -2598000000.00
CVX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 31202000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 8117000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Current Assets: 34691000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Current Debt: 6191000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 6191000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 34827000000.00
CVX cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 29000000.00
CVX cash_flow (quarterly, 2025-06-30) — Deferred Tax: 29000000.00
CVX cash_flow (quarterly, 2025-06-30) — Depletion: 65000000.00
CVX cash_flow (quarterly, 2025-06-30) — Depreciation: 4344000000.00
CVX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 4409000000.00
CVX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 4344000000.00
CVX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 1724397000.00
CVX income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.45
CVX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 2490000000.00
CVX cash_flow (quarterly, 2025-06-30) — Dividend Received Cfo: 1444000000.00
CVX income_statement (quarterly, 2025-06-30) — EBIT: 4421000000.00
CVX income_statement (quarterly, 2025-06-30) — EBITDA: 8830000000.00
CVX income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 536000000.00
CVX cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: -536000000.00
CVX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 50000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 3858000000.00
CVX cash_flow (quarterly, 2025-06-30) — End Cash Position: 5375000000.00
CVX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -5985000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Finished Goods: 6792000000.00
CVX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 4864000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -2807000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Goodwill: 4568000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 4568000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 17851000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 352035000000.00
CVX income_statement (quarterly, 2025-06-30) — Gross Profit: 13173000000.00
CVX cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 1584000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 659000000.00
CVX income_statement (quarterly, 2025-06-30) — Interest Expense: 274000000.00
CVX income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 274000000.00
CVX cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 286000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Inventory: 8813000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 175884000000.00
CVX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -3432000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 48033000000.00
CVX cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 4462000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 23276000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 23276000000.00
CVX cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
CVX cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -2590000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Minimum Pension Liabilities: -240000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Minority Interest: 841000000.00
CVX income_statement (quarterly, 2025-06-30) — Minority Interests: -25000000.00
CVX cash_flow (quarterly, 2025-06-30) — Net Business Purchase And Sale: 51000000.00
CVX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -2598000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Net Debt: 25406000000.00
CVX cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 340000000.00
CVX income_statement (quarterly, 2025-06-30) — Net Income: 2490000000.00
CVX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 2490000000.00
CVX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 2515000000.00
CVX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 2490000000.00
CVX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 2490000000.00
CVX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 2515000000.00
CVX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 2515000000.00
CVX income_statement (quarterly, 2025-06-30) — Net Interest Income: -274000000.00
CVX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
CVX cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -299000000.00
CVX cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -2590000000.00
CVX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -274000000.00
CVX cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -165000000.00
CVX cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 229000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Net PPE: 147442000000.00
CVX cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 2291000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 141849000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Non Current Accounts Receivable: 914000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 19708000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 19708000000.00
CVX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 8830000000.00
CVX income_statement (quarterly, 2025-06-30) — Normalized Income: 2490000000.00
CVX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 8576000000.00
CVX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -196000000.00
CVX income_statement (quarterly, 2025-06-30) — Operating Income: 4057000000.00
CVX income_statement (quarterly, 2025-06-30) — Operating Revenue: 44375000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1713822376.00
CVX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 4149000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -2567000000.00
CVX income_statement (quarterly, 2025-06-30) — Other Income Expense: 364000000.00
CVX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 122000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 15172000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 21893000000.00
CVX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -172000000.00
CVX income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 6926000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 5000000.00
CVX income_statement (quarterly, 2025-06-30) — Other Taxes: 1301000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Payables: 20519000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 28636000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CVX income_statement (quarterly, 2025-06-30) — Pretax Income: 4147000000.00
CVX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 11000000.00
CVX cash_flow (quarterly, 2025-06-30) — Purchase Of Business: 0.00
CVX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -9000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Raw Materials: 2021000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Receivables: 17663000000.00
CVX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 31202000000.00
CVX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 4409000000.00
CVX cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -4761000000.00
CVX cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -2598000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 205905000000.00
CVX cash_flow (quarterly, 2025-06-30) — Sale Of Business: 51000000.00
CVX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 9000000.00
CVX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 889000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Share Issued: 2442676580.00
CVX cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 4462000000.00
CVX cash_flow (quarterly, 2025-06-30) — Short Term Debt Payments: -2171000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 146417000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 141849000000.00
CVX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CVX income_statement (quarterly, 2025-06-30) — Tax Provision: 1632000000.00
CVX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.39
CVX balance_sheet (quarterly, 2025-06-30) — Total Assets: 250820000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 169693000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Total Debt: 29467000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 147258000000.00
CVX income_statement (quarterly, 2025-06-30) — Total Expenses: 40318000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 103562000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 216129000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 68735000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 1910000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 728854204.00
CVX balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 80316000000.00
CVX balance_sheet (quarterly, 2025-06-30) — Working Capital: -136000000.00
CVX income_statement (quarterly, 2025-09-30) — +Operating Expense: 10693000000.00
CVX income_statement (quarterly, 2025-09-30) — +Total Revenue: 48169000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 19073000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 17887000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -209775000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 33812000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -191000000.00
CVX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 1938922000.00
CVX income_statement (quarterly, 2025-09-30) — Basic EPS: 1.83
CVX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 5375000000.00
CVX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -4444000000.00
CVX cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -4444000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1832000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 7725000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 7727000000.00
CVX cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -3429000000.00
CVX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -4042000000.00
CVX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1929000000.00
CVX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 9385000000.00
CVX cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -231000000.00
CVX cash_flow (quarterly, 2025-09-30) — Change In Income Tax Payable: 256000000.00
CVX cash_flow (quarterly, 2025-09-30) — Change In Inventory: -920000000.00
CVX cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -153000000.00
CVX cash_flow (quarterly, 2025-09-30) — Change In Payable: 25000000.00
CVX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 25000000.00
CVX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -589000000.00
CVX cash_flow (quarterly, 2025-09-30) — Change In Receivables: 854000000.00
CVX cash_flow (quarterly, 2025-09-30) — Change In Tax Payable: 256000000.00
CVX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -783000000.00
CVX cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 929000000.00
CVX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 3414000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Common Stock: 1832000000.00
CVX cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: -3429000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 189843000000.00
CVX cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -2566000000.00
CVX income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 33179000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 10541000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Current Assets: 40866000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Current Debt: 3591000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 3591000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 35472000000.00
CVX cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 200000000.00
CVX cash_flow (quarterly, 2025-09-30) — Deferred Tax: 200000000.00
CVX cash_flow (quarterly, 2025-09-30) — Depletion: 68000000.00
CVX cash_flow (quarterly, 2025-09-30) — Depreciation: 5781000000.00
CVX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 5849000000.00
CVX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 5781000000.00
CVX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 1946035000.00
CVX income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.82
CVX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 3539000000.00
CVX cash_flow (quarterly, 2025-09-30) — Dividend Received Cfo: 1607000000.00
CVX income_statement (quarterly, 2025-09-30) — EBIT: 5784000000.00
CVX income_statement (quarterly, 2025-09-30) — EBITDA: 11633000000.00
CVX income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 981000000.00
CVX cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -981000000.00
CVX cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -6000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 4088000000.00
CVX cash_flow (quarterly, 2025-09-30) — End Cash Position: 8783000000.00
CVX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -4042000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Finished Goods: 7925000000.00
CVX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 4941000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -2831000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Goodwill: 4568000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 4568000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 18078000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 429269000000.00
CVX income_statement (quarterly, 2025-09-30) — Gross Profit: 14990000000.00
CVX cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 1388000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Income Tax Payable: 914000000.00
CVX income_statement (quarterly, 2025-09-30) — Interest Expense: 370000000.00
CVX income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 370000000.00
CVX cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 163000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Inventory: 10436000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 231387000000.00
CVX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1929000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 44398000000.00
CVX cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 5675000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 37953000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 37953000000.00
CVX cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 5675000000.00
CVX cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -906000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Minimum Pension Liabilities: -240000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Minority Interest: 5757000000.00
CVX income_statement (quarterly, 2025-09-30) — Minority Interests: -74000000.00
CVX cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 1091000000.00
CVX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -2566000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Net Debt: 33819000000.00
CVX cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -26000000.00
CVX income_statement (quarterly, 2025-09-30) — Net Income: 3539000000.00
CVX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 3539000000.00
CVX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 3613000000.00
CVX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 3539000000.00
CVX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 3539000000.00
CVX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 3613000000.00
CVX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 3613000000.00
CVX income_statement (quarterly, 2025-09-30) — Net Interest Income: -370000000.00
CVX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 2000000.00
CVX cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 2059000000.00
CVX cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 4769000000.00
CVX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -370000000.00
CVX cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -190000000.00
CVX cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 1422000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Net PPE: 219494000000.00
CVX cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -2710000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 185275000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Non Current Accounts Receivable: 987000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 29796000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 29796000000.00
CVX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 11633000000.00
CVX income_statement (quarterly, 2025-09-30) — Normalized Income: 3539000000.00
CVX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 9385000000.00
CVX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -1007000000.00
CVX income_statement (quarterly, 2025-09-30) — Operating Income: 4297000000.00
CVX income_statement (quarterly, 2025-09-30) — Operating Revenue: 48169000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1999353597.00
CVX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 4816000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -2591000000.00
CVX income_statement (quarterly, 2025-09-30) — Other Income Expense: 1487000000.00
CVX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -94000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 16188000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 23592000000.00
CVX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 506000000.00
CVX income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 7822000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 2000000.00
CVX income_statement (quarterly, 2025-09-30) — Other Taxes: 1347000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Payables: 21340000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 31881000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CVX income_statement (quarterly, 2025-09-30) — Pretax Income: 5414000000.00
CVX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 84000000.00
CVX cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
CVX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -3000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Raw Materials: 2511000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Receivables: 17887000000.00
CVX income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 33179000000.00
CVX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 5849000000.00
CVX cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -3616000000.00
CVX cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -2566000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 206006000000.00
CVX cash_flow (quarterly, 2025-09-30) — Sale Of Business: 1091000000.00
CVX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 5000000.00
CVX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1524000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Share Issued: 2442676580.00
CVX cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 0.00
CVX cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -2710000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 189843000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 185275000000.00
CVX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CVX income_statement (quarterly, 2025-09-30) — Tax Provision: 1801000000.00
CVX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.33
CVX balance_sheet (quarterly, 2025-09-30) — Total Assets: 326501000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 227796000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Total Debt: 41544000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 195600000000.00
CVX income_statement (quarterly, 2025-09-30) — Total Expenses: 43872000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 130901000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 285635000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 95429000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 2267000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 443322983.00
CVX balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 48976000000.00
CVX balance_sheet (quarterly, 2025-09-30) — Working Capital: 5394000000.00
CVX income_statement (annual, 2025-12-31) — +Operating Expense: 39412000000.00
CVX income_statement (quarterly, 2025-12-31) — +Operating Expense: 10532000000.00
CVX income_statement (annual, 2025-12-31) — +Total Revenue: 184432000000.00
CVX income_statement (quarterly, 2025-12-31) — +Total Revenue: 45787000000.00
CVX balance_sheet (annual, 2025-12-31) — Accounts Payable: 19280000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 19280000000.00
CVX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 18075000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 18075000000.00
CVX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -215226000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -215226000000.00
CVX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 33886000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 33886000000.00
CVX balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -176000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -176000000.00
CVX income_statement (annual, 2025-12-31) — Basic Average Shares: 1849217000.00
CVX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 1990448000.00
CVX income_statement (annual, 2025-12-31) — Basic EPS: 6.65
CVX income_statement (quarterly, 2025-12-31) — Basic EPS: 1.39
CVX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 8262000000.00
CVX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 8783000000.00
CVX cash_flow (annual, 2025-12-31) — Capital Expenditure: -17347000000.00
CVX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -5264000000.00
CVX cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -17347000000.00
CVX cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -5264000000.00
CVX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1445000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 1445000000.00
CVX balance_sheet (annual, 2025-12-31) — Capital Stock: 1832000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1832000000.00
CVX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 6293000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 6293000000.00
CVX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 6297000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 6297000000.00
CVX cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -12751000000.00
CVX cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -3404000000.00
CVX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -19063000000.00
CVX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -7372000000.00
CVX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -15911000000.00
CVX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4932000000.00
CVX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 33939000000.00
CVX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 10789000000.00
CVX cash_flow (annual, 2025-12-31) — Change In Account Payable: -3469000000.00
CVX cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 724000000.00
CVX cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -1310000000.00
CVX cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: 58000000.00
CVX cash_flow (annual, 2025-12-31) — Change In Inventory: 51000000.00
CVX cash_flow (quarterly, 2025-12-31) — Change In Inventory: 818000000.00
CVX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -508000000.00
CVX cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -128000000.00
CVX cash_flow (annual, 2025-12-31) — Change In Payable: -4779000000.00
CVX cash_flow (quarterly, 2025-12-31) — Change In Payable: 782000000.00
CVX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -4779000000.00
CVX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 782000000.00
CVX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -109000000.00
CVX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 266000000.00
CVX cash_flow (annual, 2025-12-31) — Change In Receivables: 3697000000.00
CVX cash_flow (quarterly, 2025-12-31) — Change In Receivables: -236000000.00
CVX cash_flow (annual, 2025-12-31) — Change In Tax Payable: -1310000000.00
CVX cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: 58000000.00
CVX cash_flow (annual, 2025-12-31) — Change In Working Capital: -1648000000.00
CVX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1502000000.00
CVX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 3829000000.00
CVX cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -189000000.00
CVX cash_flow (annual, 2025-12-31) — Changes In Cash: -1035000000.00
CVX cash_flow (quarterly, 2025-12-31) — Changes In Cash: -1515000000.00
CVX balance_sheet (annual, 2025-12-31) — Common Stock: 1832000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Common Stock: 1832000000.00
CVX cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -12751000000.00
CVX cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -3404000000.00
CVX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 186450000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 186450000000.00
CVX cash_flow (annual, 2025-12-31) — Common Stock Payments: -12079000000.00
CVX cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -2998000000.00
CVX income_statement (annual, 2025-12-31) — Cost Of Revenue: 128346000000.00
CVX income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 31232000000.00
CVX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 10763000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 10763000000.00
CVX balance_sheet (annual, 2025-12-31) — Current Assets: 38552000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Current Assets: 38552000000.00
CVX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 786000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 786000000.00
CVX balance_sheet (annual, 2025-12-31) — Current Debt: 191000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Current Debt: 191000000.00
CVX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 977000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 977000000.00
CVX balance_sheet (annual, 2025-12-31) — Current Liabilities: 33387000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 33387000000.00
CVX cash_flow (annual, 2025-12-31) — Deferred Income Tax: 986000000.00
CVX cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 277000000.00
CVX cash_flow (annual, 2025-12-31) — Deferred Tax: 986000000.00
CVX cash_flow (quarterly, 2025-12-31) — Deferred Tax: 277000000.00
CVX cash_flow (annual, 2025-12-31) — Depletion: 325000000.00
CVX cash_flow (quarterly, 2025-12-31) — Depletion: 80000000.00
CVX cash_flow (annual, 2025-12-31) — Depreciation: 20132000000.00
CVX cash_flow (quarterly, 2025-12-31) — Depreciation: 5884000000.00
CVX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 20457000000.00
CVX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 5964000000.00
CVX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 20132000000.00
CVX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 5884000000.00
CVX income_statement (annual, 2025-12-31) — Diluted Average Shares: 1855637000.00
CVX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 1996984000.00
CVX income_statement (annual, 2025-12-31) — Diluted EPS: 6.63
CVX income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.39
CVX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 12299000000.00
CVX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2770000000.00
CVX cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 5282000000.00
CVX cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 1143000000.00
CVX income_statement (annual, 2025-12-31) — EBIT: 20960000000.00
CVX income_statement (quarterly, 2025-12-31) — EBIT: 4960000000.00
CVX income_statement (annual, 2025-12-31) — EBITDA: 41417000000.00
CVX income_statement (quarterly, 2025-12-31) — EBITDA: 10924000000.00
CVX income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 3000000000.00
CVX income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 663000000.00
CVX cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -3000000000.00
CVX cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -663000000.00
CVX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 58000000.00
CVX cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 17000000.00
CVX balance_sheet (annual, 2025-12-31) — Employee Benefits: 4111000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 4111000000.00
CVX cash_flow (annual, 2025-12-31) — End Cash Position: 7285000000.00
CVX cash_flow (quarterly, 2025-12-31) — End Cash Position: 7285000000.00
CVX cash_flow (annual, 2025-12-31) — Financing Cash Flow: -19063000000.00
CVX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -7372000000.00
CVX balance_sheet (annual, 2025-12-31) — Finished Goods: 7211000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Finished Goods: 7211000000.00
CVX balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: -199000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: -199000000.00
CVX cash_flow (annual, 2025-12-31) — Free Cash Flow: 16592000000.00
CVX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 5525000000.00
CVX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2704000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -2704000000.00
CVX balance_sheet (annual, 2025-12-31) — Goodwill: 4568000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Goodwill: 4568000000.00
CVX balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 4568000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 4568000000.00
CVX balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 18251000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 18251000000.00
CVX balance_sheet (annual, 2025-12-31) — Gross PPE: 434955000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 434955000000.00
CVX income_statement (annual, 2025-12-31) — Gross Profit: 56086000000.00
CVX income_statement (quarterly, 2025-12-31) — Gross Profit: 14555000000.00
CVX cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 7304000000.00
CVX cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 1780000000.00
CVX balance_sheet (annual, 2025-12-31) — Income Tax Payable: 844000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 844000000.00
CVX income_statement (annual, 2025-12-31) — Interest Expense: 1217000000.00
CVX income_statement (quarterly, 2025-12-31) — Interest Expense: 361000000.00
CVX income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 1217000000.00
CVX income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 361000000.00
CVX cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 942000000.00
CVX cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 369000000.00
CVX balance_sheet (annual, 2025-12-31) — Inventory: 9711000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Inventory: 9711000000.00
CVX balance_sheet (annual, 2025-12-31) — Invested Capital: 225763000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 225763000000.00
CVX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -15911000000.00
CVX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -4932000000.00
CVX balance_sheet (annual, 2025-12-31) — Investments And Advances: 43867000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 43867000000.00
CVX cash_flow (annual, 2025-12-31) — Issuance Of Debt: 20218000000.00
CVX cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2273000000.00
CVX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 659000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 659000000.00
CVX balance_sheet (annual, 2025-12-31) — Long Term Debt: 39122000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 39122000000.00
CVX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 39781000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 39781000000.00
CVX cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 11402000000.00
CVX cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 236000000.00
CVX cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -4475000000.00
CVX cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -918000000.00
CVX balance_sheet (annual, 2025-12-31) — Minimum Pension Liabilities: -2509000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Minimum Pension Liabilities: -2509000000.00
CVX balance_sheet (annual, 2025-12-31) — Minority Interest: 5726000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Minority Interest: 5726000000.00
CVX income_statement (annual, 2025-12-31) — Minority Interests: -186000000.00
CVX income_statement (quarterly, 2025-12-31) — Minority Interests: -75000000.00
CVX cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -1020000000.00
CVX cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 56000000.00
CVX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -12079000000.00
CVX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -2998000000.00
CVX balance_sheet (annual, 2025-12-31) — Net Debt: 33020000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Net Debt: 33020000000.00
CVX cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 585000000.00
CVX cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 141000000.00
CVX income_statement (annual, 2025-12-31) — Net Income: 12299000000.00
CVX income_statement (quarterly, 2025-12-31) — Net Income: 2770000000.00
CVX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 12299000000.00
CVX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2770000000.00
CVX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 12485000000.00
CVX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2845000000.00
CVX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 12299000000.00
CVX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2770000000.00
CVX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 12299000000.00
CVX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2770000000.00
CVX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 12485000000.00
CVX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 2845000000.00
CVX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 12485000000.00
CVX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2845000000.00
CVX income_statement (annual, 2025-12-31) — Net Interest Income: -1217000000.00
CVX income_statement (quarterly, 2025-12-31) — Net Interest Income: -361000000.00
CVX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 1000000.00
CVX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -1000000.00
CVX cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 5866000000.00
CVX cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -924000000.00
CVX cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 6927000000.00
CVX cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -682000000.00
CVX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -1217000000.00
CVX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -361000000.00
CVX cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -469000000.00
CVX cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -103000000.00
CVX cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 2455000000.00
CVX cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 277000000.00
CVX balance_sheet (annual, 2025-12-31) — Net PPE: 219729000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Net PPE: 219729000000.00
CVX cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -1061000000.00
CVX cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -242000000.00
CVX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 181882000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 181882000000.00
CVX balance_sheet (annual, 2025-12-31) — Non Current Accounts Receivable: 1035000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Non Current Accounts Receivable: 1035000000.00
CVX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 30014000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 30014000000.00
CVX balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 30014000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 30014000000.00
CVX income_statement (annual, 2025-12-31) — Normalized EBITDA: 41417000000.00
CVX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 10924000000.00
CVX income_statement (annual, 2025-12-31) — Normalized Income: 12299000000.00
CVX income_statement (quarterly, 2025-12-31) — Normalized Income: 2770000000.00
CVX cash_flow (annual, 2025-12-31) — Operating Cash Flow: 33939000000.00
CVX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 10789000000.00
CVX cash_flow (annual, 2025-12-31) — Operating Gains Losses: -2415000000.00
CVX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -522000000.00
CVX income_statement (annual, 2025-12-31) — Operating Income: 16674000000.00
CVX income_statement (quarterly, 2025-12-31) — Operating Income: 4023000000.00
CVX income_statement (annual, 2025-12-31) — Operating Revenue: 184432000000.00
CVX income_statement (quarterly, 2025-12-31) — Operating Revenue: 45787000000.00
CVX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1980248122.00
CVX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1980248122.00
CVX balance_sheet (annual, 2025-12-31) — Other Current Assets: 4469000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 4469000000.00
CVX balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 191000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 191000000.00
CVX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 8000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 8000000.00
CVX income_statement (annual, 2025-12-31) — Other Income Expense: 4286000000.00
CVX income_statement (quarterly, 2025-12-31) — Other Income Expense: 937000000.00
CVX cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1208000000.00
CVX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -420000000.00
CVX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 16261000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 16261000000.00
CVX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 24543000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 24543000000.00
CVX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 1286000000.00
CVX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 274000000.00
CVX income_statement (annual, 2025-12-31) — Other Operating Expenses: 29056000000.00
CVX income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 7713000000.00
CVX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 4000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 4000000.00
CVX income_statement (annual, 2025-12-31) — Other Taxes: 5230000000.00
CVX income_statement (quarterly, 2025-12-31) — Other Taxes: 1327000000.00
CVX balance_sheet (annual, 2025-12-31) — Payables: 21647000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Payables: 21647000000.00
CVX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 32410000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 32410000000.00
CVX balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CVX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CVX income_statement (annual, 2025-12-31) — Pretax Income: 19743000000.00
CVX income_statement (quarterly, 2025-12-31) — Pretax Income: 4599000000.00
CVX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 370000000.00
CVX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 57000000.00
CVX cash_flow (annual, 2025-12-31) — Purchase Of Business: -2225000000.00
CVX cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
CVX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -16000000.00
CVX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -4000000.00
CVX balance_sheet (annual, 2025-12-31) — Raw Materials: 2500000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Raw Materials: 2500000000.00
CVX balance_sheet (annual, 2025-12-31) — Receivables: 18075000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Receivables: 18075000000.00
CVX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 128346000000.00
CVX income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 31232000000.00
CVX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 20457000000.00
CVX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 5964000000.00
CVX cash_flow (annual, 2025-12-31) — Repayment Of Debt: -14352000000.00
CVX cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -3197000000.00
CVX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -12079000000.00
CVX cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -2998000000.00
CVX balance_sheet (annual, 2025-12-31) — Retained Earnings: 205365000000.00
CVX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 205365000000.00
CVX cash_flow (annual, 2025-12-31) — Sale Of Business: 1205000000.00
CVX cash_flow (quarterly, 2025-12-31) — Sale Of Business: 56000000.00
CVX cash_flow (annual, 2025-12-31) — Sale Of Investment: 17000000.00
CVX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 3000000.00
CVX income_statement (annual, 2025-12-31) — Selling General And Administration: 5126000000.00
CVX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1492000000.00
CVX balance_sheet (annual, 2025-12-31) — Share Issued: 2442676580.00
CVX balance_sheet (quarterly, 2025-12-31) — Share Issued: 2442676580.00
CVX cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 8816000000.00
CVX cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 2037000000.00
CVX cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -9877000000.00
CVX cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: -2279000000.00